Helping people with HIV stay in care
Part of Infections clinical trials.
This study tests ways to help people living with HIV in Indonesia stay engaged in their care. It may help you if you want extra support to keep up with your appointments and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are living with HIV.
- You can agree to take part in the study.
- You can attend study visits.
- You do not have a condition that makes it hard to fully take part, like a serious brain, mental health, or heart problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study tests a low-barrier, mobile HIV care program designed with input from patients and other stakeholders to help people stay engaged in care and reach an undetectable viral load. It may help if you’re having trouble keeping regular HIV appointments or staying on treatment.
This study looks at how people living with HIV feel about their daily pill treatment and any stigma they may face. It aims to understand your experiences to help improve care.
This study tests a training program using actors (standardized patients) to help healthcare providers reduce HIV stigma. It focuses on providers in Vietnam who work in STD care.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This study is testing a program to reduce stigma and help women who use drugs stay engaged in HIV care. It aims to see if the program improves their health and well-being.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.